Recombinant Human TSC1 Protein，His

TSC1 (Tuberous Sclerosis Complex 1) is a critical gene involved in the regulation of cell growth and proliferation, and it plays a vital role in the Tuberous Sclerosis Complex (TSC), a genetic disorder characterized by the development of benign tumors in various organs, including the brain, kidneys, and skin. The TSC1 protein, also known as hamartin, interacts with TSC2 (tuberin) to form a heterodimer that regulates the mTOR (mammalian target of rapamycin) signaling pathway, which is crucial for cellular metabolism, growth, and autophagy. Mutations in TSC1 or TSC2 can lead to dysregulation of the mTOR pathway, contributing to tumorigenesis and a range of neurological symptoms. Given the significance of TSC1 in maintaining cellular homeostasis and its implications in cancer biology, researchers are increasingly focused on the production and characterization of recombinant TSC1 protein. This research not only aims to elucidate the molecular mechanisms governing TSC pathology but also holds potential for therapeutic interventions, such as targeted mTOR inhibitors. Investigating the structure and function of TSC1 can provide insights into its role in cellular signaling and disease progression, thus paving the way for the development of novel treatment strategies for TSC and related disorders. The availability of functional recombinant TSC1 protein is essential for these endeavors, enabling biochemical assays and structural studies that enrich our understanding of this complex disease at the molecular level.